Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-28 Purchase | 2023-10-02 4:23 pm | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 86,258 | $3.7093 | $319,954 | 89,227 (Direct) | View |
2021-12-20 Purchase | 2021-12-20 4:20 pm | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 25,000 | $0.389 | $9,725 | 336,422 (Direct) | View |
2021-06-10 Purchase | 2021-06-10 7:29 pm | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 10,000 | $1.025 | $10,250 | 311,422 (Direct) | View |
2020-11-17 Purchase | 2020-11-18 5:14 pm | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 9,090 | $2.2 | $19,998 | 143,542 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-02 Option Award | 2024-01-04 4:38 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 300,000 | $0 | 300,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:00 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Fitzpatrick Alexander A Chief Legal Officer | 700,000 | $0 | 700,000 (Direct) | View |
2022-02-18 Option Award | 2022-02-23 4:08 pm | N/A 2032-02-18 | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 300,000 | $0 | 816,422 (Direct) | View |
2021-12-31 Disposition | 2022-01-04 4:06 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 120,000 | $0 | 216,422 (Direct) | View |
2021-05-20 Tax Withholding | 2021-05-21 4:26 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 42,120 | $0.86 | 301,422 (Direct) | View |
2021-02-03 Option Award | 2021-02-03 7:57 pm | N/A 2031-02-03 | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 350,000 | $0 | 493,542 (Direct) | View |
2020-06-05 Tax Withholding | 2020-06-08 5:41 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 31,590 | $3.31 | 134,452 (Direct) | View |
2020-05-22 Tax Withholding | 2020-05-26 5:16 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 39,487 | $4.99 | 166,042 (Direct) | View |
2020-05-06 Tax Withholding | 2020-05-08 12:30 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 7,802 | $5.24 | 205,529 (Direct) | View |
2020-02-05 Option Award | 2020-02-07 4:33 pm | N/A 2030-02-05 | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 250,000 | $0 | 313,331 (Direct) | View |
2019-11-25 Tax Withholding | 2019-11-26 5:15 pm | N/A N/A | Evofem Biosciences Inc. | EVFM | Fitzpatrick Alexander A General Counsel and Secretary | 7,747 | $6.22 | 63,331 (Direct) | View |